Evidence map›Paper›PMID 35906338›Full record

ArticleClinical oral investigations2022

Impact of periodontal status on the oral mucositis in patients receiving high-dose chemotherapy.

Arife Sabancı, Basak Karasu, Halil Ibrahim Sabancı, İrfan Kuku, Omer Alperen Kırmızıgul

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Arife SabancıDepartment of Periodontology, Faculty of Dentistry, Inonu University, 44280, Malatya, Turkey. dtcicekarife@hotmail.com.ORCID http://orcid.org/0000-0002-0956-1600
Basak KarasuDepartment of Periodontology, Karatekin University, Çankırı, Turkey.ORCID http://orcid.org/0000-0001-6537-9902
Halil Ibrahim SabancıDepartment of Internal Medicine, Inonu University, Malatya, Turkey.ORCID http://orcid.org/0000-0003-3439-3933
İrfan KukuDepartment of Internal Medicine - Hematology, Inonu University, Malatya, Turkey.ORCID http://orcid.org/0000-0001-6126-0816
Omer Alperen KırmızıgulDepartment of Periodontology, Inonu University, Malatya, Turkey.ORCID http://orcid.org/0000-0001-5828-8949
Inonu University · TRÇankırı Karatekin University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOral mucositis (OM) is a frequent complication of cancer treatments. Oral mucositis and periodontal disease have a common inflammatory pattern. The purpose of this study was to evaluate the OM and its association with periodontal status in patients with hematologic malignancies who undergo high-dose chemotherapy. MATERIALS AND

methodsFifty-five patients who received high-dose chemotherapy were included in the study. Full-mouth periodontal clinical measurements including plaque index (PI), gingival index (GI), clinical attachment level (CAL), and probing depth (PD) values were recorded before the condition chemotherapy regime. OM monitoring was initiated 1 day after the chemotherapy and maintained for 20 days.

resultsTwenty-two of patients (40%) were observed oral mucositis after high-dose chemotherapy. Patients with mucositis had significantly higher GI scores than those who did not have mucositis (p < 0.05). There was a significantly moderate positive correlation between the grade of mucositis and GI scores (p < 0.05). In patients with periodontitis, the incidence of grade 1-2 mucositis was significantly higher than in the healthy group (p < 0.05). In individuals with periodontitis and gingivitis, the healing duration of mucositis was significantly longer than the healthy group (p < 0.05).

conclusionsThe results of this study showed that the severity grades of oral mucositis may increase in patients with gingival inflammation. The results also suggest that periodontal diseases may have a significant impact on the duration of oral mucositis. CLINICAL RELEVANCE: The current study contributes to our understanding of the importance of oral health status in reducing the occurrence, severity, and duration of OM in hematological cancer patients treated with high-dose chemotherapy.

Indexed as

GingivitisMucositisPeriodontal DiseasesPeriodontitisStomatitisDental Plaque IndexHumansGingivitisHigh-dose chemotherapyOral mucositisPeriodontitis

Identifiers

PMID35906338
OpenAlexW4288713728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.